238
Views
5
CrossRef citations to date
0
Altmetric
Non-Malignant Hematology

Vitamin D deficiency and its relationship with cardiac iron and function in patients with transfusion-dependent thalassemia at Chiang Mai University Hospital

ORCID Icon, , , , , & show all
Pages 52-59 | Received 30 Oct 2017, Accepted 27 Dec 2017, Published online: 23 Jan 2018

References

  • Soliman A, De Sanctis V, Yassin M. Vitamin D status in thalassemia major: an update. Mediterr J Hematol Infect Dis. 2013;5(1):e2013057. doi:10.4084/mjhid.2013.057.
  • Matter M, El-Sherbiny E, Elmougy A, Abass M, Aldossary S, Ali WA. Myocardial function in Saudi adolescents with vitamin D deficiency: Tissue Doppler imaging study. J Saudi Heart Assoc. 2016;28(1):22–30. doi:10.1016/j.jsha.2015.06.006.
  • Ambarwati L, Rahayuningsih SE, Setiabudiawan B. Association between vitamin D levels and left ventricular function and NT-proBNP levels among thalassemia major children with iron overload. Ann Pediatr Cardiol. 2016;9(2):126–131. doi:10.4103/0974-2069.181495.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385.
  • Brown SJ, Ruppe MD, Tabatabai LS. The parathyroid gland and heart disease. Methodist Debakey Cardiovasc J. 2017;13(2):49–54. doi:10.14797/mdcj-13-2-49.
  • Bansal N, Zelnick L, Robinson-Cohen C, et al. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic study of Atherosclerosis. J Am Heart Assoc. 2014;3(6):e001278. doi:10.1161/JAHA.114.001278.
  • Oudit GY, Sun H, Trivieri MG, et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med. 2003;9(9):1187–1194. doi:10.1038/nm920.
  • Billaudel BJ, Delbancut AP, Sutter BC, Faure AG. Stimulatory effect of 1,25-dihydroxyvitamin D3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats. Steroids. 1993;58(7):335–341. doi:10.1016/0039-128X(93)90094-4.
  • Smogorzewski M, Massry SG. Uremic cardiomyopathy: role of parathyroid hormone. Kidney Int Suppl. 1997;62:S12–14.
  • Wood JC, Claster S, Carson S, et al. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol. 2008;141(6):891–894. doi:10.1111/j.1365-2141.2008.07135.x.
  • Noetzli LJ, Carson S, Coates TD, Wood JC. Revisiting the relationship between vitamin D deficiency, cardiac iron and cardiac function in thalassemia major. Eur J Haematol. 2011;86(2):176–177. doi:10.1111/j.1600-0609.2010.01538.x.
  • Elhoseiny SM, Morgan DS, Rabie AM, Bishay ST. Vitamin D receptor (VDR) gene polymorphisms (FokI, BsmI) and their relation to vitamin D status in pediatrics beta thalassemia major. Indian J Hematol Blood Transfus. 2016;32(2):228–238. doi:10.1007/s12288-015-0552-z.
  • Isik P, Yarali N, Tavil B, et al. Endocrinopathies in Turkish children with beta thalassemia major: results from a single center study. Pediatr Hematol Oncol. 2014;31(7):607–615. doi:10.3109/08880018.2014.898724.
  • Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S. Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 2012;17(5):291–296. doi:10.1179/1607845412Y.0000000017.
  • Nakavachara P, Viprakasit V. Children with hemoglobin E/beta-thalassemia have a high risk of being vitamin D deficient even if they get abundant sun exposure: a study from Thailand. Pediatr Blood Cancer 2013;60(10):1683–1688. doi:10.1002/pbc.24614.
  • Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3(1):4. doi:10.1186/1472-6823-3-4.
  • Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009;146(5):546–556. doi:10.1111/j.1365-2141.2009.07793.x.
  • Walker JM. Thalassaemia major and the heart: a toxic cardiomyopathy tamed? Heart 2013;99(12):827–834. doi:10.1136/heartjnl-2012-302857.
  • Berdoukas V, Coates TD, Cabantchik ZI. Iron and oxidative stress in cardiomyopathy in thalassemia. Free Radic Biol Med. 2015;88(Pt A):3–9. doi:10.1016/j.freeradbiomed.2015.07.019.
  • Wood JC. Cardiac complications in thalassemia major. Hemoglobin 2009;33(Suppl 1):S81–86. doi:10.3109/03630260903347526.
  • Bhattacharya SK, Ahokas RA, Carbone LD, et al. Macro- and micronutrients in African-Americans with heart failure. Heart Fail Rev. 2006;11(1):45–55. doi:10.1007/s10741-006-9192-6.
  • Rai V, Agrawal DK. Role of vitamin D in cardiovascular diseases. Endocrinol Metab Clin North Am. 2017;46(4):1039–1059. doi:10.1016/j.ecl.2017.07.009.
  • Dimitriadou M, Christoforidis A, Economou M, et al. Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major. Eur J Haematol. 2010;84(1):64–71. doi:10.1111/j.1600-0609.2009.01349.x.
  • Nair S. Vitamin D deficiency and liver disease. Gastroenterol Hepatol (N Y). 2010;6(8):491–493.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.